A bis-cyclodextrin diselenide with glutathione peroxidase-like activity

被引:79
作者
Liu, JQ
Luo, GM [1 ]
Ren, XJ
Mu, Y
Bai, Y
Shen, JC
机构
[1] Jilin Univ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China
[2] Univ PLA, Changchun 130026, Peoples R China
[3] Jilin Univ, Key Lab Supramol Struct & Spect, Changchun 130023, Peoples R China
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 2000年 / 1481卷 / 02期
关键词
beta-cyclodextrin; glutathione peroxidase; imitating enzyme; selenium;
D O I
10.1016/S0167-4838(00)00130-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A diselenide, 2,2'-diseleno-bis-beta-cyclodextrin (2-SeCD), was synthesized to imitate the antioxidant enzyme glutathione peroxidase (GPX). The GPX mimic accepts a variety of hydroperoxides as substrates. The GPX activities, reduction of H2O2, tert-butyl hydroperoxide and cumenyl hydroperoxide by glutathione, are 7.4, 4.5 and 10.2 U/mu mol, respectively. In contrast to ebselen (PZ51), the diselenide displays high GPX-like activity. The reduction of hydroperoxide by glutathione in the presence of a radical trap shows that the mimic catalyzes the reaction via a non-radical mechanism. A ping-pong mechanism was observed in the steady-state kinetic studies of the 2-SeCD-catalyzed reaction. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:222 / 228
页数:7
相关论文
共 24 条
[11]  
Gamble SC, 1997, J CHEM TECHNOL BIOT, V68, P123
[12]  
GANTHER HE, 1984, METHOD ENZYMOL, V107, P593
[13]   Artificial imitation of glutathione peroxidase with 6-selenium-bridged β-cyclodextrin [J].
Liu, JQ ;
Gao, SJ ;
Luo, GM ;
Yan, GL ;
Shen, JC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (02) :397-400
[14]  
MENZ G, 1994, ANGEW CHEM INT EDIT, V33, P803
[15]   Artificial enzymes [J].
Murakami, Y ;
Kikuchi, J ;
Hisaeda, Y ;
Hayashida, O .
CHEMICAL REVIEWS, 1996, 96 (02) :721-758
[16]  
NATTERMANN A, Patent No. 44971
[17]  
Renson M, 2-Phenyl-1,2-benzisoselenazol-3(2H)-one containing pharmaceutical preparations and process for the treatment of rheumatic diseases, Patent No. [US4352799A, 4352799]
[18]  
Shen B. J., 1991, CHINESE J ORG CHEM, V11, P265
[19]  
SIES H, 1994, METHOD ENZYMOL, V234, P476
[20]  
SIES H, 1993, FREE RADIC BIOL MED, V14, P33